Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...
Background Pancreatic ductal adenocarcinoma (PDAC) is largely refractory to immune checkpoint blockade, owing to its ...
Early results from a phase 1/2 clinical study of a urine-based multi-cancer early detection (MCED) assay for prostate, bladder, and kidney cancers. This is an ASCO Meeting Abstract from the 2026 ASCO ...
Patients may not know that these treatments are experimental or about the risks they may pose. The latest in AJC's ...
The bond repair craze hasn’t slowed down—but one formula stands to me out from the rest: Epres’s Bond Repair Treatment. It’s appeared in countless viral TikTok videos in recent months, most notably as ...
In a recent update, the National Comprehensive Cancer Network (NCCN) recommended capivasertib combined with fulvestrant for hormone receptor–positive and HER2-negative locally advanced or metastatic ...
Everyday Health on MSN
The 16 best sunscreens for all budgets and skin types in 2026, tested and expert-vetted
From mineral formulas that won’t leave a white cast to lightweight options for oily skin, these 16 sunscreens stood out in ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Andrea Barnes Andrea Barnes is a writer covering large cleaning appliances.
Nicotinamide adenine dinucleotide (NAD) and its reduced form (NADH) therapy are dietary supplements that are promoted widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results